Go Pro
→ Gold majors have a big problem (From Golden Portfolio) (Ad)tc pixel Free ABT Stock Alerts

Abbott Laboratories (ABT) Short Interest Ratio & Short Volume

Abbott Laboratories logo
$102.08 -1.28 (-1.24%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$102.25 +0.17 (+0.17%)
As of 09/11/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Abbott Laboratories Short Interest Overview

As of August 31, 2026, Abbott Laboratories (ABT) had a short interest of 22.13 million shares sold short, representing 1.28% of the public float. This marks a 8.61% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.7, meaning it would take 2.7 days of the average trading volume of 7.53 million shares to cover all short positions.

Current Short Interest
22,129,750 shares
Previous Short Interest
20,375,133 shares
Change Vs. Previous Month
8.61%
Dollar Volume Sold Short
$2.44 billion
Short Interest Ratio
2.7 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
1,730,383,000 shares
Short Percent of Float
1.28%
Today's Trading Volume
8,397,423 shares
Average Trading Volume
7,532,092 shares
Today's Volume Vs. Average
111%
Short Selling Abbott Laboratories?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABT Short Interest Over Time

ABT Days to Cover Over Time

ABT Percentage of Float Shorted Over Time

Abbott Laboratories Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202622,129,750 shares $2.44 billion +8.6%1.3%2.67 $110.48
8/14/202620,375,133 shares $2.27 billion -9.9%1.2%2.86 $111.27
7/31/202622,624,184 shares $2.40 billion -8.9%1.3%1.66 $105.99
7/15/202624,846,147 shares $2.22 billion +6.2%1.4%2.14 $89.27
6/30/202623,387,895 shares $2.12 billion +6.4%1.3%1.48 $90.68
6/15/202621,974,266 shares $1.95 billion -0.3%1.3%1.77 $88.76
5/29/202622,044,423 shares $1.88 billion -5.1%1.3%1.94 $85.36
5/15/202623,222,031 shares $1.96 billion +3.0%1.3%1.7 $84.49
4/30/202622,536,486 shares $2.05 billion +3.6%1.3%1.5 $90.75
4/15/202621,746,613 shares $2.21 billion -8.7%1.3%2.26 $101.55
3/31/202623,825,745 shares $2.44 billion +19.4%1.4%1.56 $102.59
3/13/202619,950,568 shares $2.15 billion +9.4%1.2%2.26 $107.99
2/27/202618,233,629 shares $2.12 billion +6.0%1.1%2.21 $116.17
2/13/202617,198,525 shares $1.94 billion -8.2%1.0%1.52 $112.63
1/30/202618,726,478 shares $2.05 billion -6.0%1.1%1.05 $109.31
1/15/202619,914,580 shares $2.46 billion +14.5%1.2%3.31 $123.49
12/31/202517,399,553 shares $2.18 billion +9.6%1.0%3 $125.30
12/15/202515,875,548 shares $2.04 billion -14.1%0.9%2.82 $128.58
11/28/202518,485,281 shares $2.38 billion -3.4%1.1%2.25 $128.90
11/14/202519,141,411 shares $2.50 billion -5.1%1.1%3.62 $130.59
10/31/202520,171,849 shares $2.49 billion +4.2%1.2%3.3 $123.61
10/15/202519,360,000 shares $2.50 billion +6.6%1.1%3.3 $129.35
9/30/202518,170,000 shares $2.43 billion +0.6%1.1%2.9 $133.97
9/15/202518,070,000 shares $2.37 billion +1.8%1.0%2.8 $131.40
8/31/202517,750,000 shares $2.35 billion +3.7%1.0%2.8 $132.59
8/15/202517,110,000 shares $2.25 billion -6.7%1.0%2.7 $131.66
7/31/202518,330,000 shares $2.31 billion -3.8%1.1%2.8 $126.16
7/15/202519,060,000 shares $2.50 billion -1.9%1.1%2.8 $131.41
6/30/202519,430,000 shares $2.64 billion -6.6%1.1%2.9 $136.09
6/15/202520,800,000 shares $2.82 billion +3.5%1.2%3.1 $135.41
5/31/202520,090,000 shares $2.69 billion -9.8%1.2%2.9 $133.68
5/15/202522,260,000 shares $2.97 billion +5.4%1.3%3.1 $133.39
4/30/202521,120,000 shares $2.76 billion -2.6%1.2%3 $130.71
4/15/202521,690,000 shares $2.73 billion -0.5%1.3%2.9 $126.08
3/31/202521,790,000 shares $2.89 billion -0.4%1.3%3.1 $132.76
3/15/202521,880,000 shares $2.78 billion -4.6%1.3%3.3 $127.02
2/28/202522,930,000 shares $3.16 billion +2.8%1.3%3.7 $137.99
2/15/202522,310,000 shares $2.91 billion +22.3%1.3%3.9 $130.63
1/31/202518,240,000 shares $2.33 billion +21.8%1.1%3.2 $127.69
1/15/202514,970,000 shares $1.66 billion +4.5%0.9%2.7 $110.96
Bezos… DOOMED (Ad)

A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.tc pixel

Watch James Altucher's free video breakdown before the September 25 deadline.
12/31/202414,320,000 shares $1.62 billion +18.4%0.8%2.9 $113.11
12/15/202412,100,000 shares $1.37 billion -10.8%0.7%2.4 $113.38
11/30/202413,570,000 shares $1.61 billion +12.6%0.8%2.7 $118.77
11/15/202412,050,000 shares $1.40 billion -14.4%0.7%2.4 $115.90
10/31/202414,070,000 shares $1.60 billion +0.6%0.8%2.9 $113.39
10/15/202413,980,000 shares $1.62 billion +18.2%0.8%2.5 $116.04
9/30/202411,830,000 shares $1.35 billion -11.5%0.7%2 $114.01
9/15/202413,360,000 shares $1.56 billion +4.8%0.8%2.2 $116.40
8/31/202412,750,000 shares $1.44 billion +0.6%0.7%2.1 $113.27
8/15/202412,680,000 shares $1.41 billion -7.0%0.7%2 $110.95
7/31/202413,630,000 shares $1.44 billion +26.8%0.8%2 $105.96
7/15/202410,750,000 shares $1.11 billion -17.3%0.6%1.8 $102.99
6/30/202413,000,000 shares $1.35 billion +11.9%0.8%2.3 $103.91
6/15/202411,620,000 shares $1.20 billion -19.9%0.7%2 $103.68
5/31/202414,500,000 shares $1.48 billion -1.8%0.8%2.4 $102.22
5/15/202414,770,000 shares $1.54 billion +2.0%0.9%2.6 $104.56
4/30/202414,480,000 shares $1.53 billion +11.9%0.8%2.6 $105.94
4/15/202412,940,000 shares $1.41 billion -10.6%0.8%2.2 $108.89
3/31/202414,480,000 shares $1.65 billion -7.9%0.8%2.5 $113.66
3/15/202415,720,000 shares $1.80 billion +5.4%0.9%2.9 $114.43
2/29/202414,920,000 shares $1.77 billion +4.4%0.9%3 $118.56
2/15/202414,290,000 shares $1.62 billion +12.5%0.8%2.7 $113.64
1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16
1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92
12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07
12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29
11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30
11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00
10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55
10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87
9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85
9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76
8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90
8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93
7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34
7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93
6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02
6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04
5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00
5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84
4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47
4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96
3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26
3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80
2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72
2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28
1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55
1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51
12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79
12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58
11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14
10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94
10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91
9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76
9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06
8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65
8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90
7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84
7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82
6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65
6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80
5/31/202213,670,000 shares $1.61 billion +0.7%0.8%2.6 $117.46
5/15/202213,570,000 shares $1.49 billion +0.8%0.8%2.4 $109.88
4/30/202213,460,000 shares $1.53 billion +5.2%0.8%2.5 $113.50
4/15/202212,790,000 shares $1.51 billion +5.7%0.7%2.1 $117.69
3/31/202212,100,000 shares $1.43 billion -9.2%0.7%2 $118.36
3/15/202213,330,000 shares $1.57 billion +28.4%0.8%2.2 $117.48
2/28/202210,380,000 shares $1.25 billion +0.1%0.6%1.6 $120.62
2/15/202210,370,000 shares $1.29 billion +15.4%0.6%1.7 $123.98
1/31/20228,990,000 shares $1.15 billion -0.2%0.5%1.5 $127.46
1/15/20229,010,000 shares $1.15 billion +7.4%0.5%1.6 $128.16
12/31/20218,390,000 shares $1.18 billion -13.3%0.5%1.6 $140.74
12/15/20219,680,000 shares $1.31 billion +11.1%0.6%1.8 $135.56
11/30/20218,710,000 shares $1.10 billion -14.1%0.5%1.7 $125.77
11/15/202110,140,000 shares $1.31 billion -9.7%0.6%2 $129.44
10/29/202111,230,000 shares $1.45 billion +7.0%N/A2.3 $128.89
10/15/202110,500,000 shares $1.23 billion -6.4%0.6%2.3 $117.49
9/30/202111,220,000 shares $1.33 billion +1.5%0.6%2.4 $118.13
9/15/202111,050,000 shares $1.41 billion +8.1%0.6%2.4 $127.49

ABT Short Interest - Frequently Asked Questions

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 22,129,750 shares of ABT short. 1.28% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 2.7. Learn More on Abbott Laboratories's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.28% of Abbott Laboratories' floating shares are currently sold short.

Abbott Laboratories saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 22,129,750 shares, an increase of 8.6% from the previous total of 20,375,133 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.28% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies compare to Abbott Laboratories: DexCom, Inc. (4.68%), Intuitive Surgical, Inc. (2.20%), Tesla, Inc. (2.35%), AbbVie Inc. (1.11%), Boston Scientific Corporation (3.34%), Elevance Health, Inc. (2.54%), Integer Holdings Corporation (7.72%), Johnson & Johnson (0.90%), Medtronic PLC (0.95%), Thermo Fisher Scientific Inc. (1.54%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading down $1.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ABT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:ABT is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
This 38 Dollar Fund Holds Every Major AI Stock and Pays Weekly
The biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...
Investors Alley | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Why the Treasury still prices gold at 42 dollars an ounce
The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...
Golden Portfolio | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The retirement income that answers “yes” when everything else says no
Todd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...
Eagle Publishing | Sponsoredtc pixel
I called NVDA at $6 - Here's what’s next…
Matt McCall called NVDA at 6 dollars - it's since climbed more than 3,100 percent. He's identified 51 stocks t...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel